G�nter Schultz

1.0k total citations
15 papers, 869 citations indexed

About

G�nter Schultz is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, G�nter Schultz has authored 15 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Physiology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in G�nter Schultz's work include Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (5 papers) and Mast cells and histamine (3 papers). G�nter Schultz is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (5 papers) and Mast cells and histamine (3 papers). G�nter Schultz collaborates with scholars based in Germany and United States. G�nter Schultz's co-authors include Karl H. Jakobs, Klaus Aktories, Thomas Gudermann, Stefan Offermanns, Klaus-Dieter Schultz, V. A. W. Kreye, Roland Seifert, Karin Schultz, Roland Seifert and Gudrun Ahnert‐Hilger and has published in prestigious journals such as Pflügers Archiv - European Journal of Physiology, Journal of Molecular Medicine and Naunyn-Schmiedeberg s Archives of Pharmacology.

In The Last Decade

G�nter Schultz

15 papers receiving 821 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G�nter Schultz Germany 14 632 297 171 103 79 15 869
Wesley L. Terasaki United States 9 684 1.1× 173 0.6× 201 1.2× 100 1.0× 49 0.6× 10 906
Beavo Ja United States 7 492 0.8× 189 0.6× 178 1.0× 110 1.1× 36 0.5× 7 776
Debra Mullikin United States 13 834 1.3× 489 1.6× 242 1.4× 43 0.4× 119 1.5× 13 1.2k
Iain G. Dougall United Kingdom 17 528 0.8× 229 0.8× 235 1.4× 103 1.0× 84 1.1× 29 939
Yuichiro Kamikawa Japan 16 237 0.4× 250 0.8× 219 1.3× 58 0.6× 36 0.5× 55 707
Robert Wondergem United States 19 686 1.1× 287 1.0× 156 0.9× 162 1.6× 34 0.4× 35 1.2k
Donald Button United States 15 555 0.9× 295 1.0× 88 0.5× 69 0.7× 100 1.3× 23 881
Peter Roevens Belgium 17 649 1.0× 161 0.5× 224 1.3× 148 1.4× 74 0.9× 29 1.1k
Hongying Zhong United States 12 576 0.9× 302 1.0× 114 0.7× 53 0.5× 63 0.8× 13 756
Jiann-Wu Wei Canada 16 619 1.0× 248 0.8× 126 0.7× 132 1.3× 17 0.2× 45 848

Countries citing papers authored by G�nter Schultz

Since Specialization
Citations

This map shows the geographic impact of G�nter Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G�nter Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G�nter Schultz more than expected).

Fields of papers citing papers by G�nter Schultz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G�nter Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G�nter Schultz. The network helps show where G�nter Schultz may publish in the future.

Co-authorship network of co-authors of G�nter Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of G�nter Schultz. A scholar is included among the top collaborators of G�nter Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G�nter Schultz. G�nter Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gudermann, Thomas, et al.. (1995). Receptors and G proteins as primary components of transmembrane signal transduction. Journal of Molecular Medicine. 73(2). 51–63. 158 indexed citations
2.
Offermanns, Stefan & G�nter Schultz. (1994). Complex information processing by the transmembrane signaling system involving G proteins. Naunyn-Schmiedeberg s Archives of Pharmacology. 350(4). 329–38. 60 indexed citations
3.
Kleppisch, Thomas, Gudrun Ahnert‐Hilger, Maik Gollasch, et al.. (1992). Inhibition of voltage-dependent Ca2+ channels via ?2-adrenergic and opioid receptors in cultured bovine adrenal chromaffin cells. Pflügers Archiv - European Journal of Physiology. 421(2-3). 131–137. 40 indexed citations
4.
Seifert, Roland, et al.. (1989). Lack of effect of opioid peptides, morphine and naloxone on superoxide formation in human neutrophils and HL-60 leukemic cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(1). 101–6. 22 indexed citations
5.
Seifert, Roland, et al.. (1989). Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(6). 671–678. 56 indexed citations
6.
Aktories, Klaus, G�nter Schultz, & Karl H. Jakobs. (1983). Islet-activating protein impairs ? 2-adrenoceptor-mediated inhibitory regulation of human platelet adenylate cyclase. Naunyn-Schmiedeberg s Archives of Pharmacology. 324(3). 196–200. 41 indexed citations
7.
Aktories, Klaus, G�nter Schultz, & Karl H. Jakobs. (1982). Inactivation of the guanine nucleotide regulatory site mediating inhibition of the adenylate cyclase in hamster adipocytes. Naunyn-Schmiedeberg s Archives of Pharmacology. 321(4). 247–252. 28 indexed citations
8.
Aktories, Klaus, G�nter Schultz, & Karl H. Jakobs. (1980). Regulation of adenylate cyclase activity in hamster adipocytes. Naunyn-Schmiedeberg s Archives of Pharmacology. 312(2). 167–173. 85 indexed citations
9.
Schultz, Klaus-Dieter, et al.. (1980). Inhibitory effects of mepacrine and eicosatetraynoic acid on cyclic GMP elevations caused by calcium and hormonal factors in rat ductus deferens. Naunyn-Schmiedeberg s Archives of Pharmacology. 311(1). 71–77. 34 indexed citations
10.
Jakobs, Karl H. & G�nter Schultz. (1979). Different inhibitory effect of adrenaline on platelet adenylate cyclase in the presence of GTP plus cholera toxin and of stable GTP analogues. Naunyn-Schmiedeberg s Archives of Pharmacology. 310(2). 121–127. 35 indexed citations
11.
Jakobs, Karl H., Klaus Aktories, & G�nter Schultz. (1979). GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists. Naunyn-Schmiedeberg s Archives of Pharmacology. 310(2). 113–119. 151 indexed citations
12.
Schultz, Klaus-Dieter, et al.. (1979). Relaxation of hormonally stimulated smooth muscular tissues by the 8-bromo derivative of cyclic GMP. Naunyn-Schmiedeberg s Archives of Pharmacology. 306(1). 1–9. 57 indexed citations
13.
Jakobs, Karl H., et al.. (1978). Characterization of ?- and ?-adrenergic receptors linked to human platelet adenylate cyclase. Naunyn-Schmiedeberg s Archives of Pharmacology. 302(3). 285–291. 70 indexed citations
14.
Schultz, Klaus-Dieter, Karin Schultz, & G�nter Schultz. (1977). Effects of manganese on cyclic GMP levels in the rat ductus deferens. Naunyn-Schmiedeberg s Archives of Pharmacology. 298(3). 197–204. 5 indexed citations
15.
Jakobs, Karl H., Karin Schultz, & G�nter Schultz. (1972). Hemmung von Adenyl-Cyclase-Pr�parationen aus der Rattenniere durch Calciumionen und verschiedene Diuretica. Naunyn-Schmiedeberg s Archives of Pharmacology. 273(3). 248–266. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wesley L. Terasaki Breakdown of academic impact, for papers by Beavo Ja Breakdown of academic impact, for papers by Debra Mullikin Breakdown of academic impact, for papers by Iain G. Dougall Breakdown of academic impact, for papers by Yuichiro Kamikawa Breakdown of academic impact, for papers by Robert Wondergem Breakdown of academic impact, for papers by Donald Button Breakdown of academic impact, for papers by Peter Roevens Breakdown of academic impact, for papers by Hongying Zhong Breakdown of academic impact, for papers by Jiann-Wu Wei
Rankless by CCL
2026